Envista Holdings logo

Envista HoldingsNYSE: NVST

Profile

Sector:

Healthcare

Country:

United States

IPO:

18 September 2019

Next earnings report:

N/A

Last dividends:

N/A

Next dividends:

N/A
$3.67 B
-55%vs. 3y high
87%vs. sector
-vs. 3y high
-vs. sector
-41%vs. 3y high
45%vs. sector
-54%vs. 3y high
30%vs. sector

Price

regular market | 1 min ago
$21.34+$0.40(+1.91%)

Dividend

No data over the past 3 years
$601.00 M$647.68 M
$601.00 M$8.20 M

Analysts recommendations

Institutional Ownership

NVST Latest News

Deciphering Envista (NVST) International Revenue Trends
zacks.com04 November 2024 Sentiment: -

Evaluate Envista's (NVST) reliance on international revenue to better understand the company's financial stability, growth prospects and potential stock price performance.

Envista Stock Climbs on Q3 Earnings and Revenue Beat, Margins Crash
zacks.com31 October 2024 Sentiment: POSITIVE

NVST delivers better-than-expected top and bottom-line performance in the third quarter of 2024.

Compared to Estimates, Envista (NVST) Q3 Earnings: A Look at Key Metrics
zacks.com30 October 2024 Sentiment: POSITIVE

Although the revenue and EPS for Envista (NVST) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Earnings Preview: Envista (NVST) Q3 Earnings Expected to Decline
zacks.com23 October 2024 Sentiment: NEGATIVE

Envista (NVST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Envista Announces Participation in Baird's 2024 Global Healthcare Conference
prnewswire.com27 August 2024 Sentiment: POSITIVE

BREA, Calif. , Aug. 27, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") today announced that the company will participate in the Baird 2024 Global Healthcare Conference on Wednesday, September 11, 2024 from 10:50 – 11:20 am ET at the InterContinental New York Barclay.

Why Envista (NVST) International Revenue Trends Deserve Your Attention
zacks.com12 August 2024 Sentiment: POSITIVE

Examine Envista's (NVST) international revenue patterns and their implications on Wall Street's forecasts and the prospective trajectory of the stock.

Envista (NVST) Q2 Earnings & Revenues Miss, Margins Fall
zacks.com08 August 2024 Sentiment: NEGATIVE

Envista's (NVST) Spark division sales witness a slowdown in the second quarter due to the deferment of a larger portion of case revenues.

Here's What Key Metrics Tell Us About Envista (NVST) Q2 Earnings
zacks.com07 August 2024 Sentiment: POSITIVE

Although the revenue and EPS for Envista (NVST) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Envista (NVST) Q2 Earnings and Revenues Lag Estimates
zacks.com07 August 2024 Sentiment: NEGATIVE

Envista (NVST) came out with quarterly earnings of $0.11 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.43 per share a year ago.

Envista Schedules Second Quarter 2024 Earnings Call
prnewswire.com12 July 2024 Sentiment: POSITIVE

BREA, Calif. , July 12, 2024 /PRNewswire/ -- Envista Holdings Corporation (NYSE: NVST) ("Envista") will report financial results for its second quarter 2024 on Wednesday, August 7, 2024.

  • 1(current)
  • 2

What type of business is Envista Holdings?

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products. This segment also provides software packages, which include DTX Studio Implant; DTX Studio Lab; and DTX Studio Clinic, a software package offered with its imaging products. It offers its products under the Nobel Biocare, Alpha-Bio Tec, Implant Direct, Nobel Procera, Ormco, Spark, Orascoptic, Damon, Insignia, AOA brands. The Equipment & Consumables segment provides dental equipment and supplies, including digital imaging systems, software, and other visualization/magnification systems; endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents, and cements; and infection prevention products. This segment offers its products under the Dexis, DTX Studio, Kerr, Metrex, Total Care, Pentron, Optibond, Harmonize, Sonicfill, Sybron Endo, and CaviWipes to dental offices, clinics, and hospitals. Envista Holdings Corporation was incorporated in 2018 and is headquartered in Brea, California.

What sector is Envista Holdings in?

Envista Holdings is in the Healthcare sector

What industry is Envista Holdings in?

Envista Holdings is in the Medical Instruments & Supplies industry

What country is Envista Holdings from?

Envista Holdings is headquartered in United States

When did Envista Holdings go public?

Envista Holdings initial public offering (IPO) was on 18 September 2019

What is Envista Holdings website?

https://envistaco.com

Is Envista Holdings in the S&P 500?

No, Envista Holdings is not included in the S&P 500 index

Is Envista Holdings in the NASDAQ 100?

No, Envista Holdings is not included in the NASDAQ 100 index

Is Envista Holdings in the Dow Jones?

No, Envista Holdings is not included in the Dow Jones index

When was Envista Holdings the previous earnings report?

No data

When does Envista Holdings earnings report?

Next earnings report date is not announced yet